A.A. YAROVOY, I.M. GORSHKOV, E.N. KOROBOV

The S. Fyodorov Eye Microsurgery Federal State Institution, 59A, Beskudnikovskiy blvr, Moscow, Russian Federation, 127486

 Yarovoy A.A. — D. Med. Sc., Head of the Department of Ophthalmo-oncology and Radiology, tel. (499) 488-89-43, e-mail: yarovoyaa@yandex.ru

Gorshkov I.M. — Cand. Med. Sc., Head of the Department of Vitreoretinal Surgery, tel. (499) 488-89-62, e-mail: ilyagorshkov@mail.ru

Korobov E.N. — post-graduate student, e-mail: egorkorobov1991@mail.ru

 The study includes the results of treatment of 53 patients with choroidal melanoma who underwent endovitreal removal of the tumor in the period from 2011 to 2017. 8 patients operated on since February 2017 were excluded from the study due to short observation periods. Out of 43 patients, 23 (53.5 %) were male and 20 (46.5 %) were female. The age of the patients was from 25 to 84 years (on average 55.05 ± 12.9 years). Primary endoresection of choroidal melanoma was performed in 22 patients, secondary — in 21 patients. If the primary endorsection of choroidal melanoma is performed, then the obligatory stage is brachytherapy by attaching beta-applicator with radionuclide Ruthenium-106 to the episcler on the tumor bed projection. The mean follow-up period was 18.25 months (range from 6 to 54 months, standard deviation 12.37 months). None of the patients experienced recurrences in the choroid, conjunctiva, or into the orbit. At the indicated time of observation, the eyes were preserved in all patients, the maximum corrected visual acuity was: ≥0.5 — 2 (5 % patients), ≤0.1 <0.5 — 16 (37 % patients), <0.1 — 25 (58 % patients). Endoresection of choroidal melanoma allows to avoid enucleation and maintain vision when treating large choroidal melanomas. It can be an alternative to radiotherapy to preserve vision in the eyes with juxtapapillary choroidal melanoma localization.

Key words: uveal melanoma, choroidal melanoma, endoresection.

References

1. Bechrakis N.E., Bornfeld N., Zoller et all. Iodine 125 plaque brachytherapy versus trans-scleral tumor resection in the treatment of large uveal melanomas. Ophthalmology, 2002, no. 109, pp. 1855-1861.
2. Linnik L.F., Legoshin V.A., Shigina N.A. Experimental substantiation of microsurgical intraocular removal of tumors of the choroid in combination with laser coagulation. Laser methods of treatment and angiographic research in ophthalmology. Sat. Scientific, 1983, pp. 78-81.
3. Peyman G.A., Barrada A. Retinochoroidectomy ab interno, Ophthalmic Surg, 1984, Vol. 15, no. 9, pp. 749–751.
4. Damato B., Groenewald C., McGalliard J., Wong D.. Endoresectionof choroidal  Br J Ophthalmol, 1998, no. 82, pp. 213-218.
5. Yarovoy A.A., Gorshkov I.M., Golubeva O.V.. Endovitreal removal of uveal melanoma: five years of experience. Effective pharmacotherapy. Oncology, hematology and radiology. Special edition of «Melanoma», 2016, no. 39, pp. 64-68.
6. Caminal J.M., Mejia K., Masuet-Aumadell C et all. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma. Am J Ophthalmology, 2013, no. 156, pp. 334-342.
7. Garcia-Arumi J., Leila M., Zapata M.A., Velazquez D., Dinares-Fernandez M.C., Tresserra F., Corostegui B. Endoresection technique with/without brachyterapy for management of high posterior choroidal melanoma: extended follow-up results. Retina, 2015, no. 35, pp. 628-637.
8. Karkhaneh R., Chams H., Amoli F.A. et all. Long-term surgical outcome of posterior choroidal melanoma treated by endoresection. Retina, 2007, no. 27, pp. 908-1014.
9. Kertes P., Johnson J.J., Peyman G.A. Internal resection of posterior uveal melanomas. Ophthalmol, 1998, no. 82. pp. 1147-1153.
10. Konstantinidis L., Groenewald C., Couplan S.E., Damato B. Long-term outcome of primary endoresection of choroidal melanoma. Br J Ophthalmol, 2014, no. 98, pp. 82-85.
11. Rice J.C., Stannard C., Cook C., Lecuona K. et all. Brachytherapy and endoresection for choroidal melanoma: a cohort study. Br J Ophthalmol, 2014, no. 98, pp. 86-91.
12. Sussskind D., Durr C., Paulsen et al. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients — the Tuebingen experience. Acta Ophthalmol, 2016, no. 3, pp. 1-7.
13. Boyko E.V., Zhogolev K.S., Ivanov P.I. et al. Experience of treating patients with melanoma of the choroid with the help of the radiosurgical device «Gamma-knife». Modern technologies in ophthalmology. Modern technologies of treatment of vitreoretinal pathology, 2016, no.1, pp. 40-43.
14. Chang M.Y., McCannel T.A. Local treatment failure after globe-conserving therapy for choroidal melanoma. Br J Ophthalmol, 2013, no. 97, pp. 804-811.
15. Schonfeld S., Cordini D., Riechardt A.I., et al. Proton beam therapy leads to excellent local control rates in choroidal melanoma in the intermediate fundus zone. Am J Ophthalmology, 2014, no. 158, pp. 1184-1191.
16. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no.28. Arch Ophthalmol, 2006, no. 124, pp. 1684-1693.
17. Shishkin M.M., Reznikova A.B. Combined endoresection of large choroidal melanomas, analysis of long-term results and complications. Sci. Tr. Scientific-practical. Conf. On ophthalmic surgery with international participation «East-West», 2012, no. 1, pp. 479-481.
18. Sinyavsky O.A., Troyanovsky R.L., Ivanov P.I. et al. Indications for resection and its features in the combined organ-preserving treatment of uveal melanoma with the use of the Gamma knife. Modern technologies in ophthalmology. Modern technologies of treatment of vitreoretinal pathology, 2016, no.1, pp. 201-204.
19. Korobov E.N., Yarovoy A.A., Gorshkov I.M. Primary endoresection of choroidal melanoma: meta-analysis of publications. Modern technologies in ophthalmology. Modern technologies of treatment of vitreoretinal pathology, 2017, no.1, pp.142-145.